Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis

BACKGROUND: Indacaterol/glycopyrronium (IND/GLY) is approved for maintenance treatment of adult patients with COPD. This post hoc analysis explored the efficacy and safety of IND/GLY versus salmeterol/fluticasone (SFC) in symptomatic (Global Initiative for Chronic Obstructive Lung Disease [GOLD] B a...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogelmeier, Claus, Zhong, Nanshan, Humphries, Michael J, Mezzi, Karen, Fogel, Robert, Bader, Giovanni, Patalano, Francesco, Banerji, Donald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5167461/
https://www.ncbi.nlm.nih.gov/pubmed/28008244
http://dx.doi.org/10.2147/COPD.S116786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5167461/
https://www.ncbi.nlm.nih.gov/pubmed/28008244
http://dx.doi.org/10.2147/COPD.S116786

Ejemplares similares